These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 9149805)
1. Use of the acute phase serum amyloid A2 (SAA2) gene promoter in the analysis of pro- and anti-inflammatory mediators: differential kinetics of SAA2 promoter induction by IL-1 beta and TNF-alpha compared to IL-6. Uhlar CM; Grehan S; Steel DM; Steinkasserer A; Whitehead AS J Immunol Methods; 1997 Apr; 203(2):123-30. PubMed ID: 9149805 [TBL] [Abstract][Full Text] [Related]
2. The kinetics and magnitude of the synergistic activation of the serum amyloid A promoter by IL-1 beta and IL-6 is determined by the order of cytokine addition. Uhlar CM; Whitehead AS Scand J Immunol; 1999 Apr; 49(4):399-404. PubMed ID: 10219766 [TBL] [Abstract][Full Text] [Related]
3. In vitro evaluation of an enhanced human serum amyloid A (SAA2) promoter-regulated soluble TNF receptor fusion protein for anti-inflammatory gene therapy. Rygg M; Uhlar CM; Thorn C; Jensen LE; Gaughan DJ; Varley AW; Munford RS; Göke R; Chen Y; Whitehead AS Scand J Immunol; 2001 Jun; 53(6):588-95. PubMed ID: 11422907 [TBL] [Abstract][Full Text] [Related]
4. Differential glucocorticoid enhancement of the cytokine-driven transcriptional activation of the human acute phase serum amyloid A genes, SAA1 and SAA2. Thorn CF; Whitehead AS J Immunol; 2002 Jul; 169(1):399-406. PubMed ID: 12077270 [TBL] [Abstract][Full Text] [Related]
5. Differential transcription of the mouse acute phase serum amyloid A genes in response to pro-inflammatory cytokines. Thorn CF; Whitehead AS Amyloid; 2002 Dec; 9(4):229-36. PubMed ID: 12557750 [TBL] [Abstract][Full Text] [Related]
6. Regulation of the human acute phase serum amyloid A genes by tumour necrosis factor-alpha, interleukin-6 and glucocorticoids in hepatic and epithelial cell lines. Thorn CF; Lu ZY; Whitehead AS Scand J Immunol; 2004 Feb; 59(2):152-8. PubMed ID: 14871291 [TBL] [Abstract][Full Text] [Related]
7. IL-1 receptor antagonist (IL-1Ra) does not inhibit the production of C-reactive protein or serum amyloid A protein by human primary hepatocytes. Differential regulation in normal and tumour cells. Gabay C; Genin B; Mentha G; Iynedjian PB; Roux-Lombard P; Guerne PA Clin Exp Immunol; 1995 May; 100(2):306-13. PubMed ID: 7743670 [TBL] [Abstract][Full Text] [Related]
8. Posttranscriptional regulation of acute phase serum amyloid A2 expression by the 5'- and 3'-untranslated regions of its mRNA. Longley DB; Steel DM; Whitehead AS J Immunol; 1999 Oct; 163(8):4537-45. PubMed ID: 10510397 [TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory properties of human serum IgA: induction of IL-1 receptor antagonist and Fc alpha R (CD89)-mediated down-regulation of tumour necrosis factor-alpha (TNF-alpha) and IL-6 in human monocytes. Wolf HM; Hauber I; Gulle H; Samstag A; Fischer MB; Ahmad RU; Eibl MM Clin Exp Immunol; 1996 Sep; 105(3):537-43. PubMed ID: 8809146 [TBL] [Abstract][Full Text] [Related]
10. Synergy between deacetylase inhibitors and IL-1beta in activation of the serum amyloid A2 gene promoter. Blais M; Désilets A; Asselin C DNA Cell Biol; 2005 Apr; 24(4):209-17. PubMed ID: 15812237 [TBL] [Abstract][Full Text] [Related]
11. Induction of prostaglandin H synthase-2 and tumor necrosis factor-alpha in human amnionic WISH cells by various stimuli occurs through distinct intracellular mechanisms. Hulkower KI; Otis ER; Li J; Ennis BW; Cugier DJ; Bell RL; Carter GW; Glaser KB J Pharmacol Exp Ther; 1997 Feb; 280(2):1065-74. PubMed ID: 9023325 [TBL] [Abstract][Full Text] [Related]
12. Suppression of the constitutive expression of cytochrome P-450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6. Chen JQ; Ström A; Gustafsson JA; Morgan ET Mol Pharmacol; 1995 May; 47(5):940-7. PubMed ID: 7538197 [TBL] [Abstract][Full Text] [Related]
13. Down-regulation of the major circulating precursors of proteins deposited in secondary amyloidosis by a recombinant mouse interleukin-1 receptor antagonist. Grehan S; Herbert J; Whitehead AS Eur J Immunol; 1997 Oct; 27(10):2593-9. PubMed ID: 9368615 [TBL] [Abstract][Full Text] [Related]
14. Synergistic activation of serum amyloid A (SAA) by IL-6 and IL-1 in combination on human Hep 3B hepatoma cell line. Role of PGE2 and IL-1 receptor antagonist. Conti P; Bartle L; Barbacane RC; Reale M; Placido FC; Sipe J Immunol Invest; 1995 Mar; 24(3):523-35. PubMed ID: 7790046 [TBL] [Abstract][Full Text] [Related]
15. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. Tilg H; Vannier E; Vachino G; Dinarello CA; Mier JW J Exp Med; 1993 Nov; 178(5):1629-36. PubMed ID: 7693853 [TBL] [Abstract][Full Text] [Related]
16. The role of NF-kappa B and NF-IL6 transactivating factors in the synergistic activation of human serum amyloid A gene expression by interleukin-1 and interleukin-6. Betts JC; Cheshire JK; Akira S; Kishimoto T; Woo P J Biol Chem; 1993 Dec; 268(34):25624-31. PubMed ID: 8244997 [TBL] [Abstract][Full Text] [Related]
17. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis. Matsukawa A; Yoshimura T; Miyamoto K; Ohkawara S; Yoshinaga M Lab Invest; 1997 May; 76(5):629-38. PubMed ID: 9166282 [TBL] [Abstract][Full Text] [Related]
18. Synergistic induction of mouse serum amyloid A3 promoter by the inflammatory mediators IL-1 and IL-6. Huang JH; Liao WS J Interferon Cytokine Res; 1999 Dec; 19(12):1403-11. PubMed ID: 10638709 [TBL] [Abstract][Full Text] [Related]